The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Powl Brian T. since 2023.
This trader's CIK number is 1934232.
At the time of last reporting, Powl Brian T. was the Chief Commercial Officer of Kura Oncology, Inc.. (stock ticker symbol KURA).
Also see all insider trading activities at Kura Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FATE | 0 | $0 | 3,854 | $18,768 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KURA | 0 | $0 | 1,583 | $12,461 | 0 | $0 |
1. Fate Therapeutics Inc (FATE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-05 | FATE | Sale | 3,854 | 4.87 | 18,768 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-28 | KURA | Sale | 1,583 | 7.87 | 12,461 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Powl Brian T. (Chief Commercial Officer of Kura Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.